Find Loxapine Succinate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

104 RELATED EXCIPIENT COMPANIES

156EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 27833-64-3, Loxapine succinate salt, Loxapac, Cloxazepin, Daxolin, Loxapine (succinate)
Molecular Formula
C22H24ClN3O5
Molecular Weight
445.9  g/mol
InChI Key
YQZBAXDVDZTKEQ-UHFFFAOYSA-N
FDA UNII
X59SG0MRYU

Loxapine Succinate
An antipsychotic agent used in schizophrenia.
1 2D Structure

Loxapine Succinate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
2.1.2 InChI
InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
2.1.3 InChI Key
YQZBAXDVDZTKEQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
X59SG0MRYU
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine

2. Cl 71,563

3. Cl-71,563

4. Cl71,563

5. Cloxazepine

6. Hydrochloride, Loxapine

7. Loxapine

8. Loxapine Hydrochloride

9. Loxapine Monohydrochloride

10. Loxapinsuccinate

11. Loxipine Maleate

12. Loxipine Succinate

13. Loxitane

14. Maleate, Loxipine

15. Oxilapine

16. Succinate, Loxapine

2.3.2 Depositor-Supplied Synonyms

1. 27833-64-3

2. Loxapine Succinate Salt

3. Loxapac

4. Cloxazepin

5. Daxolin

6. Loxapine (succinate)

7. Loxapine, Succinate

8. Cl 71563

9. Loxapine,succinate

10. X59sg0mryu

11. Nsc-759578

12. Cl-71563

13. Cpd000058470

14. Mls000069383

15. Butanedioic Acid, Compd. With 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)

16. Ncgc00016160-02

17. Lederle

18. Smr000058470

19. Cas-27833-64-3

20. Dsstox_cid_25227

21. Dsstox_rid_80764

22. Dsstox_gsid_45227

23. 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Succinate (1:1)

24. Chebi:6549

25. Loxapine Succinate [usan]

26. Butanedioic Acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine

27. Butanedioic Acid, Compd. With 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)

28. Ccris 1917

29. Az-004

30. Sr-01000002971

31. Einecs 248-682-0

32. Unii-x59sg0mryu

33. Loxapine Succinate [usan:usp]

34. Staccato-loxapine

35. Loxitane (tn)

36. Prestwick_304

37. Mfcd00069298

38. Lopac-l-106

39. Opera_id_1518

40. Loxapine Succinate (usp)

41. 2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine Succinate

42. Schembl41643

43. Maprotilinehydrochloride

44. Mls000758291

45. Mls001146961

46. Mls001401432

47. Mls002222201

48. Spectrum2300242

49. Loxapine Succinate Salt, Solid

50. Regid_for_cid_71399

51. Loxapine Succinate [mi]

52. Chembl1201155

53. Dtxsid3045227

54. Hms1568k06

55. Hms1922l14

56. Hms2051e05

57. Hms2093n20

58. Hms2095k06

59. Hms2232n05

60. Hms3262o21

61. Hms3374f02

62. Hms3393e05

63. Hms3652o10

64. Hms3712k06

65. Hms3885h03

66. Loxapine Succinate [vandf]

67. Pharmakon1600-02300242

68. Loxapine Succinate [mart.]

69. Loxapine Succinate [usp-rs]

70. Loxapine Succinate [who-dd]

71. Tox21_110311

72. Tox21_500720

73. Az-104

74. Ccg-39497

75. Hy-17390a

76. Nsc759578

77. S4086

78. Akos015994711

79. Tox21_110311_1

80. Cs-4285

81. Ks-1083

82. Lp00720

83. Nc00011

84. Nsc 759578

85. Loxapine Succinate [orange Book]

86. Ncgc00016160-01

87. Ncgc00016160-03

88. Ncgc00016160-04

89. Ncgc00016160-05

90. Ncgc00021145-11

91. Ncgc00094068-01

92. Ncgc00094068-02

93. Ncgc00094068-03

94. Ncgc00261405-01

95. Loxapine Succinate [usp Monograph]

96. Succinic Acid, Compd. With 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)

97. Succinic Acid, Compound With 2-chloro-11-(4-methylpiperazin-1-yl)dibenz(b,f)(1,4)oxazepine (1:1)

98. Eu-0100720

99. Ft-0653022

100. Sw196603-4

101. Vu0239541-8

102. D00794

103. F14786

104. 833l643

105. Sr-01000002971-2

106. Sr-01000002971-6

107. Sr-01000002971-9

108. W-107092

109. Q27107236

110. 2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine Succinate

111. 2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepinesuccinate

112. Loxapine Succinate, United States Pharmacopeia (usp) Reference Standard

113. (e)-2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine Succinate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 445.9 g/mol
Molecular Formula C22H24ClN3O5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass445.1404486 g/mol
Monoisotopic Mass445.1404486 g/mol
Topological Polar Surface Area103 Ų
Heavy Atom Count31
Formal Charge0
Complexity542
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameLoxapine succinate
Drug LabelLoxapine, a dibenzoxazepine compound, represents a subclass of tricyclic antipsychotic agents, chemically distinct from the thioxanthenes, butyrophenones, and phenothiazines. Chemically, it is 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxaze...
Active IngredientLoxapine succinate
Dosage FormCapsule
RouteOral
Strengtheq 5mg base; eq 50mg base; eq 10mg base; eq 25mg base
Market StatusPrescription
CompanyLannett Holdings; Watson Labs; Mikah Pharma; Mylan

2 of 2  
Drug NameLoxapine succinate
Drug LabelLoxapine, a dibenzoxazepine compound, represents a subclass of tricyclic antipsychotic agents, chemically distinct from the thioxanthenes, butyrophenones, and phenothiazines. Chemically, it is 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxaze...
Active IngredientLoxapine succinate
Dosage FormCapsule
RouteOral
Strengtheq 5mg base; eq 50mg base; eq 10mg base; eq 25mg base
Market StatusPrescription
CompanyLannett Holdings; Watson Labs; Mikah Pharma; Mylan

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antipsychotic Agents

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)


Dopamine Antagonists

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632940200,"product":"LOXAPINE SUCCINATE USP [ACTIVE PHARMACEU","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"M\/S.","customerCountry":"UNITED STATES","quantity":"48.00","actualQuantity":"48","unit":"KGS","unitRateFc":"2400","totalValueFC":"113830.9","currency":"USD","unitRateINR":174437.5,"date":"30-Sep-2021","totalValueINR":"8373000","totalValueInUsd":"113830.9","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"4991561","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627583400,"product":"LOXAPINE SUCCINATE","address":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"36.50","actualQuantity":"36.5","unit":"KGS","unitRateFc":"881","totalValueFC":"32533.3","currency":"USD","unitRateINR":"66427.4","date":"30-Jul-2021","totalValueINR":"2424600.1","totalValueInUsd":"32533.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"4875191","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR,BEHIND MAITRIVANAM, AMEERPET,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637692200,"product":"LOXAPINE SUCCINATE APL 135-00","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"881","totalValueFC":"35537.5","currency":"USD","unitRateINR":"66163.1","date":"24-Nov-2021","totalValueINR":"2646524","totalValueInUsd":"35537.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"6393773","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640284200,"product":"LOXAPINE SUCCINATE (CERT. NO.:WATSON\/CUS\/B04\/21-22\/187 DT:23.12.2021)","address":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI","city":"GARDEN CITY OFF WESTERN EXPR HIGHWA","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"1195","totalValueFC":"195569.8","currency":"USD","unitRateINR":"92194.3","date":"24-Dec-2021","totalValueINR":"14751080","totalValueInUsd":"195569.8","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"6821495","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"","customerAddress":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648665000,"product":"LOXAPINE SUCCINATE LOT NO:A-220029","address":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI","city":"GARDEN CITY OFF WESTERN EXPR HIGHWA","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"0.32","actualQuantity":"0.32","unit":"KGS","unitRateFc":"1195","totalValueFC":"385.8","currency":"USD","unitRateINR":"91895.5","date":"31-Mar-2022","totalValueINR":"29406.56","totalValueInUsd":"385.8","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"8081952","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677781800,"product":"201035 4000140 LOXAPINE SUCCINATE","address":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI","city":"GARDEN CITY OFF WESTERN EXPR HIGHWA","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"120.00","actualQuantity":"120","unit":"KGS","unitRateFc":"1195","totalValueFC":"145578.7","currency":"USD","unitRateINR":"99782.5","date":"03-Mar-2023","totalValueINR":"11973900","totalValueInUsd":"145578.7","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"4894014","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678127400,"product":"LOXAPINE SUCCINATE","address":"OFFICE NO. 606,607,608, Shapath-5, OPP. KARNAVATI CLUB, S.G. HIGHWAY,","city":"AHMEDABAD","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"800","totalValueFC":"8121.5","currency":"USD","unitRateINR":"66800","date":"07-Mar-2023","totalValueINR":"668000","totalValueInUsd":"8121.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"4944379","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"OFFICE NO. 606,607,608, Shapath-5, OPP. KARNAVATI CLUB, S.G. HIGHWAY,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713897000,"product":"LOXAPINE SUCCINATE, LOT NO. 104230330","address":"817 DEVPATH BESIDE LAL BUNGLOW","city":"AHMEDABAD ,GUJ","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"STALLION LABORATORIES","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"800","totalValueFC":"32342.1","currency":"USD","unitRateINR":"67520","date":"24-Apr-2024","totalValueINR":"2700800","totalValueInUsd":"32342.1","indian_port":"Ahmedabad Air","hs_no":"29349990","bill_no":"3181256","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"POLIGONO INDUSTRIAL DE CELRA17460 CELRA GIRONA, SPAINSDNF ES","customerAddress":"817 DEVPATH BESIDE LAL BUNGLOW"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731004200,"product":"LOXAPINE SUCCINATE","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"55.56","actualQuantity":"55.56","unit":"KGS","unitRateFc":"716","totalValueFC":"40210.4","currency":"USD","unitRateINR":"61074.2","date":"08-Nov-2024","totalValueINR":"3393282.55","totalValueInUsd":"40210.4","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6580023","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"FRUCTUOS GELABERT 6-8,08970 SANT JO AN DESPI BARCELONA. SPAIN. SDNF Spain","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731004200,"product":"LOXAPINE SUCCINATE","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"MEDICHEM S.A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"64.44","actualQuantity":"64.44","unit":"KGS","unitRateFc":"716","totalValueFC":"46637.1","currency":"USD","unitRateINR":"61074.2","date":"08-Nov-2024","totalValueINR":"3935621.45","totalValueInUsd":"46637.1","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6580023","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"FRUCTUOS GELABERT 6-8,08970 SANT JO AN DESPI BARCELONA. SPAIN. SDNF Spain","customerAddress":"PLOT NO.2, MAITRIVIHAR,"}]
30-Jul-2021
08-Nov-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Coating Systems & Additives

read-more
read-more

Empty Capsules

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Coloring Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Parenteral

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Loxapine Succinate Manufacturers

A Loxapine Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loxapine Succinate, including repackagers and relabelers. The FDA regulates Loxapine Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loxapine Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Loxapine Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Loxapine Succinate Suppliers

A Loxapine Succinate supplier is an individual or a company that provides Loxapine Succinate active pharmaceutical ingredient (API) or Loxapine Succinate finished formulations upon request. The Loxapine Succinate suppliers may include Loxapine Succinate API manufacturers, exporters, distributors and traders.

click here to find a list of Loxapine Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Loxapine Succinate USDMF

A Loxapine Succinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Loxapine Succinate active pharmaceutical ingredient (API) in detail. Different forms of Loxapine Succinate DMFs exist exist since differing nations have different regulations, such as Loxapine Succinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Loxapine Succinate DMF submitted to regulatory agencies in the US is known as a USDMF. Loxapine Succinate USDMF includes data on Loxapine Succinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Loxapine Succinate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Loxapine Succinate suppliers with USDMF on PharmaCompass.

Loxapine Succinate WC

A Loxapine Succinate written confirmation (Loxapine Succinate WC) is an official document issued by a regulatory agency to a Loxapine Succinate manufacturer, verifying that the manufacturing facility of a Loxapine Succinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Loxapine Succinate APIs or Loxapine Succinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Loxapine Succinate WC (written confirmation) as part of the regulatory process.

click here to find a list of Loxapine Succinate suppliers with Written Confirmation (WC) on PharmaCompass.

Loxapine Succinate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Loxapine Succinate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Loxapine Succinate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Loxapine Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Loxapine Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Loxapine Succinate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Loxapine Succinate suppliers with NDC on PharmaCompass.

Loxapine Succinate GMP

Loxapine Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Loxapine Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loxapine Succinate GMP manufacturer or Loxapine Succinate GMP API supplier for your needs.

Loxapine Succinate CoA

A Loxapine Succinate CoA (Certificate of Analysis) is a formal document that attests to Loxapine Succinate's compliance with Loxapine Succinate specifications and serves as a tool for batch-level quality control.

Loxapine Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Loxapine Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Loxapine Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Loxapine Succinate EP), Loxapine Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loxapine Succinate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty